FRG1 anticorps (C-Term)
Aperçu rapide pour FRG1 anticorps (C-Term) (ABIN952390)
Antigène
Voir toutes FRG1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 229-257, C-Term
-
Specificité
- This antibody recognizes Human FRG1 (C-term).
-
Purification
- Protein A column, followed by peptide affinity purification
-
Immunogène
- KLH conjugated synthetic peptide between 229-257 amino acids from the C-terminal region of Human FRG1
-
Isotype
- Ig Fraction
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.25 mg/mL
-
Buffer
- PBS containing 0.09 % (W/V) Sodium Azide as preservative
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freezing and thawing.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- FRG1 (FSHD Region Gene 1 (FRG1))
-
Autre désignation
- FRG1
-
Sujet
- This gene maps to a location 100 kb centromeric of the repeat units on chromosome 4q35 which are deleted in facioscapulohumeral muscular dystrophy (FSHD). It is evolutionarily conserved and has related sequences on multiple human chromosomes but DNA sequence analysis did not reveal any homology to known genes. In vivo studies demonstrate the encoded protein is localized to the nucleolus.Synonyms: FSHD region gene 1 protein
-
Poids moléculaire
- 29172 Da
-
ID gène
- 2483
-
NCBI Accession
- NP_004468
Antigène
-